Pursuit of Personalized Anticancer Therapy: Leveraging Collaboration Between Academia and the Biotech/Pharmaceutical Industry

Author:

Buck Elizabeth,Mulvihill Mark,Iwata Kenneth K.

Publisher

Wiley

Subject

General Medicine

Reference33 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

2. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia;Arteaga;J Clin Oncol,2001

3. The EGF receptor family as targets for cancer therapy;Mendelsohn;Oncogene,2000

4. Development of a Targeted Treatment for Cancer

5. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors;Sato;Mol Biol Med,1983

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Molecular toxicology: Recombinant DNA technology;Encyclopedia of Toxicology;2024

2. Flagrant Practices in the Pharmaceutical Industry A Consultancy Project;SSRN Electronic Journal;2017

3. The High Costs of “Free” Drug Samples;Clinical and Translational Gastroenterology;2014-12

4. Enhancing cancer care in areas of limited resources: our next steps;Future Oncology;2014-10

5. In Sickness and in Health: A Shotgun Marriage That Is Flourishing;Collaborative Innovation in Drug Discovery;2014-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3